Benzodiazepine withdrawal in older people: what is the prevalence, what are the signs, and which patients?
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Purpose Benzodiazepines (BZDs) and related drugs (Z-drugs) are mainly taken chronically, and older people are much more likely to take them on a chronic basis despite recommendations. Withdrawal symptoms could be an obstacle to stopping BZD/Z-drug administration. The main objective of this study is to estimate the prevalence of withdrawal symptoms in patients aged 65 years and older who have experience a stop of BZD/Z-drug. The secondary objectives are to describe the withdrawal symptoms and identify factors associated.Method This ancillary study was based on a national observational study in patients with chronic BZD/Z-drug consumption. Patients who made at least one BZD/Z-drug stop experience were selected. Withdrawal symptoms are described, and a logistic regression was carried out to identify the variables most associated with withdrawal symptoms.Results In total, 697 patients were selected: 78% experienced at least one withdrawal symptom after a stop administering BZDs or Z-drugs; most of the withdrawal symptoms were psychological disorders.Conclusion Our study identifies a specific population experiencing withdrawal symptoms and who cannot stop administering BZD/Z-drug. We assume that withdrawal symptoms in patients with chronic use play an essential role in the nonstop use of BZD/Z-drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chronic use of BZDs has been linked to a decline in cognitive function, increased risk of dementia and dementia-like illnesses, and impaired sensory and motor function in the elderly, as well as aggressive behavior and expressive anger in a subset of consumers [15,75].”
From Benzodiazepines: Uses, Dangers, and Clinical Considerations (2021) · cites this paper as [15]
In the citing paper
“Long-acting BZDs are a component of mainstay therapy to prevent BZD withdrawals seizures [15].”
From Benzodiazepines: Uses, Dangers, and Clinical Considerations (2021) · cites this paper as [15]
In the citing paper
“In Z-drugs users, the occurrence of withdrawal symptoms has been associated 68 with longer duration of hypnotic use, lower level of schooling, non-medical use of hypnotics, previous failed attempts at withdrawal, and the presence of a negative impact on health.”
From Z-drug abuse and dependence: Clinical guideline of the Brazilian Academy of Neurology for diagnosis and management (2025) · cites this paper as [68]
Citations
Cites
Addiction: Part I. Benzodiazepines--side effects, abuse risk and alternatives.
Longo, L. P., & Johnson, B. (2000) · PubMed · Cited by 420
Fava, G. A., Benasi, G., Lucente, M., Offidani, E., Cosci, F., & Guidi, J. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000491524 · Cited by 209
Benzodiazepine use and risk of dementiaA nested case–control study
Lagnaoui, R., Bégaud, B., MOORE, N., Chaslerie, A., FOURRIER, A., Letenneur, L., Dartigues, J., & Moride, Y. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00453-x · Cited by 157
Practical Geriatrics: Use of Benzodiazepines Among Elderly Patients
Bogunovic, O. J., & Greenfield, S. F. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.3.233 · Cited by 132
Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users
Baandrup, L., Ebdrup, B. H., Rasmussen, J. Ø., Lindschou, J., Gluud, C., & Glenthøj, B. Y. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011481.pub2 · Cited by 128
Benzodiazepines: More Behavioural Addiction than Dependence
de las Cuevas, C., Sanz, E., & de la Fuente, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1376-8 · Cited by 113
IS THERE A RATIONALE FOR PRESCRIPTION OF BENZODIAZEPINES IN THE ELDERLY? REVIEW OF THE LITERATURE
Petrovic, M., Mariman, A., Warie, H., Afschrift, M., & Pevernagie, D. (2003) · Acta Clinica Belgica · doi:10.1179/acb.2003.58.1.004 · Cited by 76
[Epidemiology of the use of anxiolytic and hypnotic drugs in France and in the world].
Pélissolo, A., Boyer, P., Lépine, J., & Bisserbe, J. C. (1996) · PubMed · Cited by 62
Cloos, J.-M., Bocquet, V., Rolland-Portal, I., Koch, P., & Chouinard, G. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000434755 · Cited by 57
Behavioral Toxicity Revisited: Iatrogenic Comorbidity in Psychiatric Evaluation and Treatment
Fava, G. A., Cosci, F., Offidani, E., & Guidi, J. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000570 · Cited by 55
Clinical guidelines on antidepressant withdrawal urgently need updating
Davies, J., Read, J., Hengartner, M. P., Cosci, F., Fava, G., Chouinard, G., van Os, J., Nardi, A., Gøtzsche, P., Groot, P., et al. (2019) · BMJ · doi:10.1136/bmj.l2238 · Cited by 44
Benzodiazepines and the elderly a review of potential problems
Closser, M. H. (1991) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(91)90025-6 · Cited by 43
Are Seniors Dependent on Benzodiazepines? A National Clinical Survey of Substance Use Disorder
Victorri‐Vigneau, C., Laforgue, E., Grall‐Bronnec, M., Guillou-Landréat, M., Rousselet, M., Guerlais, M., FAN‐Network, Feuillet, F., & Jolliet, P. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2025 · Cited by 31
Self-citationBenzodiazepine use and wine consumption in the French elderly
Lagnaoui, R., Moore, N. D., Dartigues, J., Fourrier, A., & Bégaud, B. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01456.x · Cited by 18
Laforgue, E., Jobert, A., Rousselet, M., Grall‐Bronnec, M., FAN network, Jolliet, P., Feuillet, F., & Victorri‐Vigneau, C. (2020) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5307 · Cited by 12
Self-citationUsage des benzodiazépines chez les personnes âgées : état des connaissances
Rouleau, A., Proulx, C., O’Connor, K. P., Bélanger, C., & Dupuis, G. (2004) · Santé mentale au Québec · doi:10.7202/008621ar · Cited by 7
Psychiatric Epidemiology in Quebec: An Overview
Kovess, V., Valla, J., & Tousignant, M. (1990) · The Canadian Journal of Psychiatry · doi:10.1177/070674379003500509 · Cited by 5
Cited by
Benzodiazepines: Uses, Dangers, and Clinical Considerations
Edinoff, A. N., Nix, C. A., Hollier, J., Sagrera, C. E., Delacroix, B. M., Abubakar, T., Cornett, E. M., Kaye, A. M., & Kaye, A. D. (2021) · Neurology International · doi:10.3390/neurolint13040059 · Cited by 340
“Chronic use of BZDs has been linked to a decline in cognitive function, increased risk of dementia and dementia-like illnesses, and impaired sensory and motor function in the elderly, as well as aggressive behavior and expressive anger in a subset of consumers [15,75].”
BackgroundDiscontinuation of psychotropic medication: a synthesis of evidence across medication classes.
Vinkers, C. H., Kupka, R. W., Penninx, B. W., Ruhé, H. G., van Gaalen, J. M., van Haaren, P. C. F., Schellekens, A. F. A., Jauhar, S., Ramos-Quiroga, J. A., Vieta, E., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02445-4 · Cited by 51
“[84, 85].”
Lynch, T., Ryan, C., & Cadogan, C. A. (2022) · Health Expectations · doi:10.1111/hex.13392 · Cited by 24
“drawal symptoms often vary considerably in duration and severity, which further adds to the challenge of successful BZRA discontinuation.(28) Withdrawal symptoms (‘Reinforcement’) were a key barrier that affected participants across both cohorts.”
BackgroundFactors affecting hallucinations in patients with delirium
Tachibana, M., Inada, T., Ichida, M., & Ozaki, N. (2021) · Scientific Reports · doi:10.1038/s41598-021-92578-1 · Cited by 25
Melatonin for Insomnia in Medical Inpatients: A Narrative Review
Salahub, C. M., Wu, P. E., Burry, L. D., Soong, C., Sheehan, K., MacMillan, T. E., & Lapointe‐Shaw, L. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010256 · Cited by 19
“After prolonged use, attempts to wean these medications can cause withdrawal symptoms, such as insomnia, anxiety, and tremors [61,62].”
Background
Metadata
- Authors
- Jobert, A., Laforgue, E.-J., Grall-Bronnec, M., Rousselet, M., Péré, M., Jolliet, P., FAN-Network, Barjoux, C., Batisse, A., Boucher, A., Caous, A.-S., Daveluy, A., Eiden, C., Fournier-Choma, C., Frauger, E., Gibaja, V., Guerlais, M., Jouanjus, E., Le Boisselier, R., Pain, S., Feuillet, F., & Victorri-Vigneau, C.
- Affiliations
- Inserm (FR)
- Centre Hospitalier Universitaire de Nantes (FR)
- Corresponding author
- Jobert, Alexandra
- ORCID
- Venue
- European Journal of Clinical Pharmacology
- Published
- 2020-10-02
- Volume
- 77
- Issue
- 2
- Pages
- 171-177
- ISSN
- 0031-6970 (ISSN-L)
- 1432-1041
- OpenAlex
- W3090918451
- Cited by
- 24
- References
- 17
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 6 · 2022: 2 · 2021: 4
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- European Journal of Clinical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Direction de l’hospitalisation et de l’offre de Soins
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- benzodiazepine withdrawal, Z-drugs, older adults, chronic benzodiazepine use, benzodiazepine discontinuation
- MeSH terms
- Aged, Mental Disorders, Benzodiazepines, Female, Humans, Hypnotics and Sedatives, Male, Nervous System Diseases, Prospective Studies, Substance Withdrawal Syndrome, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.